Who Owns Ocular Therapeutix Stock?
NASDAQ: OCULHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 97.12%
- Held by insiders
- 1.44%
- Institutional holders
- 348
- Institutions 97.1%
- Insiders 1.4%
- Public and other 1.4%
Who owns Ocular Therapeutix stock?
Institutional investors own about 97.1% of Ocular Therapeutix's shares, spread across 348 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 1.44% of OCUL.
The largest institutional holders are FMR, LLC (15.07%), Blackrock Inc. (9.08%) and Deep Track Capital, Lp (8.95%). Together, the top 10 institutions control 61.6% of shares outstanding. In their latest filings, 8 of the top 10 institutions increased their OCUL positions and 0 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of OCUL
| Institution | Shares | % Held | Change |
|---|---|---|---|
| FMR, LLC | 33.16M | 15.07% | +1.0% |
| Blackrock Inc. | 19.97M | 9.08% | +3.1% |
| Deep Track Capital, Lp | 19.69M | 8.95% | 0.0% |
| Avoro Capital Advisors LLC | 12.54M | 5.70% | +1.8% |
| Summer Road LLC | 12.46M | 5.66% | +2.1% |
| Venrock Adviser, LLC | 10.35M | 4.70% | 0.0% |
| Vanguard Capital Management LLC | 8.94M | 4.06% | +1.2% |
| Price (T.Rowe) Associates Inc | 7.62M | 3.46% | +29.3% |
| State Street Corporation | 5.58M | 2.53% | +6.5% |
| Logos Global Management LP | 5.30M | 2.41% | +37.7% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of OCUL
| Fund | Shares | % Held |
|---|---|---|
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund | 9.80M | 4.46% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 6.62M | 3.01% |
| iShares Trust-iShares Russell 2000 ETF | 5.56M | 2.53% |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company K6 Fund | 2.75M | 1.25% |
| Fidelity Mt. Vernon Street Trust-Fidelity Series Growth Company Fund | 2.46M | 1.12% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 2.26M | 1.03% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 2.00M | 0.91% |
| T. Rowe Price New Horizons Fund, Inc. | 1.79M | 0.81% |
| iShares Trust-iShares Russell 2000 Growth ETF | 1.67M | 0.76% |
| Invesco Exchange-Traded Fund Trust-Invesco Pharmaceuticals ETF | 1.60M | 0.73% |
Frequently asked questions
Who is the largest shareholder of Ocular Therapeutix?
FMR, LLC is the largest institutional shareholder of OCUL, owning 15.07% of shares outstanding (33.16M shares) as of its latest 13F filing.
What percentage of Ocular Therapeutix is owned by institutions?
Institutions own about 97.1% of OCUL shares and 98.5% of the public float.
How much of Ocular Therapeutix do insiders own?
Insiders, such as officers and directors, own about 1.44% of OCUL shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.